This series supports education for allied health and cancer care professionals with the convenience of live and on-demand virtual learning opportunities. Tailored to the challenges surrounding the delivery of value-based, quality patient care, this program features national experts that represent the multidisciplinary cancer care team. The State Society Education Series is a complimentary member benefit sponsored by eleven state societies.
One complexity surrounding biosimilars lies in the essence of their variability. Learn from Sandy Werking, Sandoz Pharmaceuticals, as she explains the underpinnings of biologics. You’ll also get an overview of the FDA’s recently published draft guidelines for demonstrating biosimilar interchangeability and more!
Managing Your Patients’ Immune-Related Adverse Events (irAEs)
Brianna Hoffner, MSN, NP, RN
University of Colorado, School of Medicine
As the spectrum of immune-related adverse events (irAEs) expands to include less common, albeit more severe manifestations, early detection becomes increasingly vital for patient safety and treatment tolerability. If diagnosed quickly and managed properly, most irAEs are reversible. Watch this webinar to gain a deeper understanding of this growing spectrum and learn how to effectively manage your patients’ irAEs using a multidisciplinary approach.
Creating Partnerships Between Oncology Nurse Navigators & Oncology Practices
Tricia Strusowski, RN, MS,
Oncology Solutions, LLC
Learn how cancer programs are successfully collaborating with nurse navigators to decrease admissions and emergency room visits, adhere to national guidelines, provide survivorship care plans, and deliver successful outcomes. The case studies presented in this webinar will demonstrate alignment with patient-centered, value-based models such as the Oncology Care Model (OCM) and more!
Adapting to USP <800> and What the Changes Will Mean for Oncology Practices
Willis Triplett, PharmD
Comply797 and Comply800
Download this presentation for an overview of existing USP <800> regulations and standards, learn how new changes will impact your practice's care of hazardous drugs, and more!
Steps to Success: Implementing Oral Oncolytics
Peter Schlickman, PharmD, BCOP
Sarah Cannon Research Institute
Oral agents offer benefits to both patients and providers. Because patients self-administer oral anticancer drugs at home, travel to treatment and time spent in the cancer center or physician office can be reduced. However, oral therapies present challenges in terms of patient compliance with treatment regimens, monitoring of side effects, and the cost of treatment.
How to Navigate Patient Financial Toxicity
Dan Sherman, MA, LPC
The NaVectis Group
Financial toxicity is one of the newest side effects of cancer care treatment for both patients and cancer programs. With a growing underinsured patient population and rising costs of care, the need to prepare patients for financial burdens is crucial. Benefit from the latest trends, effective practices, and strategies to better position your program to support patients as they deal with the financial issues surrounding cancer diagnosis and treatment.
Chemotherapy Safe Handling: What You Need to Know
Martha (Marty) Polovich, PhD, RN, AOCN
Georgia State University
Explore the requirements and recommendations for safe chemotherapy handling to establish your own chemotherapy program or ensure your existing program is being managed as safely as possible.
Biosimilars: Implications for Medical Oncology
The Cancer Policy Group, LLC
With the approval of the first biosimilar in March of 2015, questions regarding this new class of products—what they are, how they are regulated, how they are covered and reimbursement policies, and what implications they have for the quality and safety of care—have taken on a new urgency. This webinar addresses these questions from the perspective of medical oncology.
Changes to ABIM’s Maintenance of Certification Program
Strategic Communications at ABIM
Intended for physicians, this webinar will explain what Maintenance of Certification (MOC) is, why it is required, and how physicians can fulfill the requirements.
Financial Counseling Role-Play: Conversations with Patients and Caregivers
Catherine Credeur, LMSW, OSW-C
UT Southwestern Medical Center
Sarah Cannon Cancer Center
This webinar focused on the financial counseling work we all do in our daily lives. The presenters introduced role-playing as a means of preparing for difficult financial conversations. The role-play scenarios provided in this program can be applied in daily practice to help with the financial challenges patients face.
New Strategies in Melanoma: Molecular Testing
Amit Jain, MD, MPH
Tallahassee Memorial Healthcare Hematology and Cancer Specialists
FSU College of Medicine
This presentation focused on the efficacy and use of molecular markers in the treatment of melanoma. This program was sponsored through a grant provided by Bristol-Myers Squibb.